Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences — Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amtech Systems, Inc. (NASDAQ:ASYS), NL Industries, Inc. (NYSE:NL), Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), Sientra, Inc. (NASDAQ:SIEN), Dorian LPG Ltd. (NYSE:LPG), and Assembly Biosciences, Inc. (NASDAQ:ASMB), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ASYS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ASYS
NL DOWNLOAD: http://Fundamental-Markets.com/register/?so=NL
DOVA DOWNLOAD: http://Fundamental-Markets.com/register/?so=DOVA
SIEN DOWNLOAD: http://Fundamental-Markets.com/register/?so=SIEN
LPG DOWNLOAD: http://Fundamental-Markets.com/register/?so=LPG
ASMB DOWNLOAD: http://Fundamental-Markets.com/register/?so=ASMB

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Amtech Systems, Inc. (NASDAQ:ASYS), NL Industries, Inc. (NYSE:NL), Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), Sientra, Inc. (NASDAQ:SIEN), Dorian LPG Ltd. (NYSE:LPG), and Assembly Biosciences, Inc. (NASDAQ:ASMB) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 14th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

AMTECH SYSTEMS, INC. (ASYS) REPORT OVERVIEW

Amtech's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Amtech reported revenue of $41.20MM vs $47.76MM (down 13.74%) and basic earnings per share $0.33 vs $0.25 (up 32.00%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, Amtech reported revenue of $164.52MM vs $120.31MM (up 36.75%) and basic earnings per share $0.68 vs -$0.53. Amtech is expected to report earnings on November 19th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.51. The estimated EPS forecast for the next fiscal year is $0.27 and is expected to report on November 19th, 2018.

To read the full Amtech Systems, Inc. (ASYS) report, download it here: http://Fundamental-Markets.com/register/?so=ASYS

-----------------------------------------

NL INDUSTRIES, INC. (NL) REPORT OVERVIEW

NL Industries' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, NL Industries reported revenue of $32.39MM vs $30.00MM (up 7.94%) and basic earnings per share -$0.87 vs $0.85. For the twelve months ended December 31st, 2017 vs December 31st, 2016, NL Industries reported revenue of $112.04MM vs $108.92MM (up 2.86%) and basic earnings per share $2.38 vs $0.31 (up 667.74%). NL Industries is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018.

To read the full NL Industries, Inc. (NL) report, download it here: http://Fundamental-Markets.com/register/?so=NL

-----------------------------------------

DOVA PHARMACEUTICALS, INC. (DOVA) REPORT OVERVIEW

Dova Pharmaceuticals' Recent Financial Performance

Dova Pharmaceuticals is expected to report earnings on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.38. The estimated EPS forecast for the next fiscal year is -$1.90 and is expected to report on February 21st, 2019.

To read the full Dova Pharmaceuticals, Inc. (DOVA) report, download it here: http://Fundamental-Markets.com/register/?so=DOVA

-----------------------------------------

SIENTRA, INC. (SIEN) REPORT OVERVIEW

Sientra's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Sientra reported revenue of $17.55MM vs $8.17MM (up 114.89%) and basic earnings per share -$0.73 vs -$1.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Sientra reported revenue of $36.54MM vs $20.73MM (up 76.24%) and basic earnings per share -$3.34 vs -$2.20. Sientra is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.74. The estimated EPS forecast for the next fiscal year is -$2.05 and is expected to report on March 12th, 2019.

To read the full Sientra, Inc. (SIEN) report, download it here: http://Fundamental-Markets.com/register/?so=SIEN

-----------------------------------------

DORIAN LPG LTD. (LPG) REPORT OVERVIEW

Dorian LPG's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Dorian LPG reported revenue of $27.64MM vs $41.03MM (down 32.62%) and basic earnings per share -$0.38 vs -$0.12. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Dorian LPG reported revenue of $159.33MM vs $167.45MM (down 4.84%) and basic earnings per share -$0.38 vs -$0.03. Dorian LPG is expected to report earnings on November 2nd, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.23. The estimated EPS forecast for the next fiscal year is -$0.42 and is expected to report on June 21st, 2019.

To read the full Dorian LPG Ltd. (LPG) report, download it here: http://Fundamental-Markets.com/register/?so=LPG

-----------------------------------------

ASSEMBLY BIOSCIENCES, INC. (ASMB) REPORT OVERVIEW

Assembly Biosciences' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Assembly Biosciences reported revenue of $3.22MM vs $2.36MM (up 36.39%) and basic earnings per share -$1.30 vs -$0.78. Assembly Biosciences is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.71. The estimated EPS forecast for the next fiscal year is -$3.99 and is expected to report on March 14th, 2019.

To read the full Assembly Biosciences, Inc. (ASMB) report, download it here: http://Fundamental-Markets.com/register/?so=ASMB

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.